mRNA |
SID 26681509 |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
0.0002 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
0.0002 |
mRNA |
PF-184 |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0002 |
mRNA |
GSK461364 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0002 |
mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0002 |
mRNA |
SN-38 |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
0.0002 |
mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.0003 |
mRNA |
tivozanib |
GDSC1000 |
pan-cancer |
AAC |
-0.14 |
0.0003 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0003 |
mRNA |
piperlongumine:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0003 |